[go: up one dir, main page]

ATE350398T1 - Protein s polypeptide und deren verwendungen - Google Patents

Protein s polypeptide und deren verwendungen

Info

Publication number
ATE350398T1
ATE350398T1 AT99202141T AT99202141T ATE350398T1 AT E350398 T1 ATE350398 T1 AT E350398T1 AT 99202141 T AT99202141 T AT 99202141T AT 99202141 T AT99202141 T AT 99202141T AT E350398 T1 ATE350398 T1 AT E350398T1
Authority
AT
Austria
Prior art keywords
polypeptides
protein
useful
antibodies
c4bp
Prior art date
Application number
AT99202141T
Other languages
English (en)
Inventor
John H Griffin
Jose A Fernandez
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/907,190 external-priority patent/US5321123A/en
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of ATE350398T1 publication Critical patent/ATE350398T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT99202141T 1991-07-02 1992-07-02 Protein s polypeptide und deren verwendungen ATE350398T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72474691A 1991-07-02 1991-07-02
US07/907,190 US5321123A (en) 1991-07-02 1992-07-01 Protein S polypeptides and anti-peptide antibodies that inhibit protein S binding to C4B binding protein, diagnostic systems and therapeutic methods

Publications (1)

Publication Number Publication Date
ATE350398T1 true ATE350398T1 (de) 2007-01-15

Family

ID=27111033

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99202141T ATE350398T1 (de) 1991-07-02 1992-07-02 Protein s polypeptide und deren verwendungen
AT92915841T ATE189232T1 (de) 1991-07-02 1992-07-02 Protein-s polypeptide und deren verwendungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT92915841T ATE189232T1 (de) 1991-07-02 1992-07-02 Protein-s polypeptide und deren verwendungen

Country Status (10)

Country Link
EP (2) EP0524737A3 (de)
AT (2) ATE350398T1 (de)
AU (1) AU674496B2 (de)
CA (1) CA2112701C (de)
DE (2) DE69233673T2 (de)
DK (2) DK0972781T3 (de)
ES (2) ES2279598T3 (de)
GR (1) GR3033242T3 (de)
PT (1) PT592600E (de)
WO (1) WO1993001209A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863896A (en) * 1995-11-09 1999-01-26 Immuno Ag Evaluation of substances for altering and for increasing APC response
SE9604378D0 (sv) * 1996-11-27 1996-11-27 Tac Ab Methods and reagents for determining protein S
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
CA2522984A1 (en) * 2003-04-18 2004-10-28 Novartis Ag Methods and compositions targeting tyrosine kinases for the diagnosis and treatment of osteoarthritis
FR2863616A1 (fr) * 2003-12-12 2005-06-17 Stago Diagnostica Dosage de la proteine s libre non clivee par le facteur xa et utilisation de ce dosage pour l'evaluation du potentiel de coagulation
US20080161425A1 (en) * 2005-07-29 2008-07-03 Universiteit Van Maastricht Regulation of Tissue Factor Activity by Protein S and Tissue Factor Pathway Inhibitor
CN115916835A (zh) * 2020-05-05 2023-04-04 维嘉治疗公司 蛋白质s抗体，其制造方法及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3789284T2 (de) * 1986-12-15 1994-07-14 Teijin Ltd Immunologische Bestimmung von freiem menschlichem Protein-S und c4bp-Protein-S-Komplex.
EP0315447A3 (de) * 1987-11-06 1990-07-18 Teijin Limited Verfahren zur immunologischen Bestimmung von humanem Protein S sowie Reagens und Kit dafür
JPH01231893A (ja) * 1988-03-14 1989-09-18 Fuji Yakuhin Kogyo Kk 抗ヒトプロテインｓモノクローナル抗体およびその利用

Also Published As

Publication number Publication date
DK0972781T3 (da) 2007-03-05
DE69233673T2 (de) 2007-10-04
EP0592600A1 (de) 1994-04-20
WO1993001209A1 (en) 1993-01-21
AU674496B2 (en) 1997-01-02
ES2279598T3 (es) 2007-08-16
PT592600E (pt) 2000-05-31
AU2323092A (en) 1993-02-11
ES2142317T3 (es) 2000-04-16
GR3033242T3 (en) 2000-09-29
EP0592600B1 (de) 2000-01-26
DK0592600T3 (da) 2000-04-17
EP0524737A2 (de) 1993-01-27
EP0592600A4 (de) 1994-10-12
CA2112701C (en) 2007-09-25
DE69230614D1 (de) 2000-03-02
EP0524737A3 (en) 1994-10-05
DE69233673D1 (de) 2007-02-15
DE69230614T2 (de) 2000-06-21
ATE189232T1 (de) 2000-02-15
CA2112701A1 (en) 1993-01-21

Similar Documents

Publication Publication Date Title
LU91087I2 (fr) Advate(Octocog alfa) soustotes ses formes protégées par le brevet de base.
ATE132197T1 (de) Monoklonale antikörper
DE68925275D1 (de) Endotoxin-bindeprotein und dessen verwendung
EP2060631A3 (de) Charakterisierung granulocytischer Ehrlichien und Verfahren zu ihrer Anwendung
EP0641861A3 (de) Verfahren zur Herstellung von hydrophoben Polypeptiden, Proteinen und Peptiden.
IL105769A0 (en) Immobilized buffered gels and membranes of hydroxy group-containing polymers
ATE327328T1 (de) Adipozyten-spezifische protein homologe
EP1780219A3 (de) Protein-S-Polypeptide und deren Verwendung
DE69233673D1 (de) Protein S polypeptide und deren Verwendungen
DE69637130D1 (de) Immunoreaktive und immunotherapeutische moleküle welche in individuen mit insulin-abhängiger diabetes mellitus interagieren
NO922421D0 (no) Collagenbindende protein, samt fremstilling derav
FI904087A7 (fi) Monoklonaalisia vasta-aineita aktivoituja ras-proteiineja vastaan, joi lla on aminohappomutaatioita proteiinin kohdassa 13
SE9002212D0 (sv) Igg binding protein
DE69327167D1 (de) Nukleotidsequenzen die fur proteine von cryptosporidium kodieren, polypeptide, welche durch diese sequenzen kodiert werden, und kits fur deren benutzung
PT524421E (pt) Herpesvirus humano tipo 6 proteina p 100, sequencias de adn correspondentes, preparacao e utilizacao
DE69534738D1 (de) Leukocyten-aktivierender Faktor
IL130960A0 (en) Novel ifn receptor 1 binding proteins dna encoding them and methods of modulating cellular response to interferons
ATE193021T1 (de) Lipoprotein (a)-peptide und deren verwendung
ATE180497T1 (de) Quecksilberbindende polypeptide und diese kodierende nukleotide
DK222390A (da) Heparin-bindende proteiner, dna'er, der koder for saadanne proteiner, fremgangsmaade til fremstilling af proteinerne same farmaceutiske praeparater indeholdende disse
TH43074A (th) โปรตีนเชื่อมกลูโคสดีไฮโดรจีเนส และการใช้ของมันในระบบการแสดงลักษณะ

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0972781

Country of ref document: EP

REN Ceased due to non-payment of the annual fee